Siste oppdatering :
19/11/2024
Infostab
Lister
Sammendrag
Søk etter kompatibilitet
Y-side kompatibilitetstabell
Referanser
Forskerteamet
valistab
plakat
Tilkoblinger
sponsorer
Forfatter
Instruksjon
Nyhetsbrev
Referanser 4102
Type :
Journal
Forskerteamet :
Auckland - Faculty of Medical and Health Sciences, University of Auckland
Forfattere :
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y.
Tittel :
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
Nummer :
J Oncol Pharm Practice ;25,4:831-840. 2018
Nivå of Evidence :
fysisk stabilitet :
kjemisk stabilitet :
andre metoder :
Kommentarer :
Lister
Doxorubicin hydrochloride
Etoposide phosphate
Vincristine sulfate
2-6°C
Vincristine sulfate
0,005 mg/ml
Doxorubicin hydrochloride
0,12 mg/ml
Etoposide phosphate
0,6 mg/ml
14
2-6°C
Vincristine sulfate
0,01 mg/ml
Doxorubicin hydrochloride
0,24 mg/ml
Etoposide phosphate
1,2 mg/ml
14
2-6°C
Vincristine sulfate
0,016 mg/ml
Doxorubicin hydrochloride
0,4 mg/ml
Etoposide phosphate
2 mg/ml
14
35°C
Vincristine sulfate
0,005 mg/ml
Doxorubicin hydrochloride
0,12 mg/ml
Etoposide phosphate
0,6 mg/ml
7
35°C
Vincristine sulfate
0,01 mg/ml
Doxorubicin hydrochloride
0,24 mg/ml
Etoposide phosphate
1,2 mg/ml
7
35°C
Vincristine sulfate
0,016 mg/ml
Doxorubicin hydrochloride
0,4 mg/ml
Etoposide phosphate
2 mg/ml
7
Mentions Légales